Matches in SemOpenAlex for { <https://semopenalex.org/work/W2949948293> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W2949948293 abstract "Background One third of the axial spondyloarthritis (axSpA) patients suffers from acute anterior uveitis (AAU). Correspondently, AAU can be the first sign of axSpA and previous studies described undetected axSpA in up to 40% of the patients with noninfectious AAU. Objectives To study whether referral of all patients with AAU and chronic back pain results in a high prevalence of newly diagnosed axSpA patients. Methods A prospective ongoing observational study was started in April 2017, including all patients with noninfectious AAU and a history of back pain (≥3 months, started Results Between April 2017 and October 2018, 65 patients were referred to the Rheumatology clinic, of whom 50 (mean age 42 years; 48% female; median back pain duration 15 years) met all inclusion criteria. AxSpA was diagnosed in 13 patients (26%), of whom seven fulfilled the criteria for radiographic and six for non-radiographic axSpA (table 1). Another 21 patients (42%) were considered clinically suspicious for early axSpA, of whom four had SI joint abnormalities and two even fulfilled the mNY criteria for sacroiliitis. Forty-two% of all patients had a high disease activity score (ASDAS≥2.1). Patients diagnosed with axSpA were significantly more often male and HLA-B27 positive, had more SpA features and a higher BASMI score. In 25 patients treatment was started, mostly with nonsteroidal anti-inflammatory drugs. Two patients received a tumor necrosis factor inhibitor shortly after diagnosis. Conclusion In this study, 26% of the patients referred with noninfectious AAU and chronic back pain (≥3 months, started Disclosure of Interests Rianne van Bentum: None declared, Frank Verbraak: None declared, Sanne Wolf: None declared, Jenny Ongkosuwito: None declared, Stevie Tan: None declared, Irene van der Horst-Bruinsma Grant/research support from: MSD, Pfizer, AbbVie, Consultant for: Abbvie, UCB, MSD, Novartis, Speakers bureau: BMS, AbbVie, Pfizer, MSD" @default.
- W2949948293 created "2019-06-27" @default.
- W2949948293 creator A5015972997 @default.
- W2949948293 creator A5016608842 @default.
- W2949948293 creator A5023005617 @default.
- W2949948293 creator A5024273092 @default.
- W2949948293 creator A5052961001 @default.
- W2949948293 creator A5075004101 @default.
- W2949948293 date "2019-06-01" @default.
- W2949948293 modified "2023-09-28" @default.
- W2949948293 title "SAT0353 HIGH PREVALENCE OF NEWLY DIAGNOSED AXIAL SPONDYLOARTHRITIS IN PATIENTS WITH ACUTE ANTERIOR UVEITISAND CHRONIC BACK PAIN – PRELIMINARY RESULTS OF THE SP-EYE STUDY" @default.
- W2949948293 doi "https://doi.org/10.1136/annrheumdis-2019-eular.805" @default.
- W2949948293 hasPublicationYear "2019" @default.
- W2949948293 type Work @default.
- W2949948293 sameAs 2949948293 @default.
- W2949948293 citedByCount "1" @default.
- W2949948293 countsByYear W29499482932019 @default.
- W2949948293 crossrefType "proceedings-article" @default.
- W2949948293 hasAuthorship W2949948293A5015972997 @default.
- W2949948293 hasAuthorship W2949948293A5016608842 @default.
- W2949948293 hasAuthorship W2949948293A5023005617 @default.
- W2949948293 hasAuthorship W2949948293A5024273092 @default.
- W2949948293 hasAuthorship W2949948293A5052961001 @default.
- W2949948293 hasAuthorship W2949948293A5075004101 @default.
- W2949948293 hasBestOaLocation W29499482931 @default.
- W2949948293 hasConcept C126322002 @default.
- W2949948293 hasConcept C142724271 @default.
- W2949948293 hasConcept C1862650 @default.
- W2949948293 hasConcept C204787440 @default.
- W2949948293 hasConcept C2776213234 @default.
- W2949948293 hasConcept C2776501849 @default.
- W2949948293 hasConcept C2777402515 @default.
- W2949948293 hasConcept C2778579456 @default.
- W2949948293 hasConcept C2781118164 @default.
- W2949948293 hasConcept C71924100 @default.
- W2949948293 hasConceptScore W2949948293C126322002 @default.
- W2949948293 hasConceptScore W2949948293C142724271 @default.
- W2949948293 hasConceptScore W2949948293C1862650 @default.
- W2949948293 hasConceptScore W2949948293C204787440 @default.
- W2949948293 hasConceptScore W2949948293C2776213234 @default.
- W2949948293 hasConceptScore W2949948293C2776501849 @default.
- W2949948293 hasConceptScore W2949948293C2777402515 @default.
- W2949948293 hasConceptScore W2949948293C2778579456 @default.
- W2949948293 hasConceptScore W2949948293C2781118164 @default.
- W2949948293 hasConceptScore W2949948293C71924100 @default.
- W2949948293 hasLocation W29499482931 @default.
- W2949948293 hasOpenAccess W2949948293 @default.
- W2949948293 hasPrimaryLocation W29499482931 @default.
- W2949948293 hasRelatedWork W1976632804 @default.
- W2949948293 hasRelatedWork W2261724355 @default.
- W2949948293 hasRelatedWork W2324039947 @default.
- W2949948293 hasRelatedWork W2326298325 @default.
- W2949948293 hasRelatedWork W2326346598 @default.
- W2949948293 hasRelatedWork W2335222928 @default.
- W2949948293 hasRelatedWork W4200322391 @default.
- W2949948293 hasRelatedWork W4256685576 @default.
- W2949948293 hasRelatedWork W4281286897 @default.
- W2949948293 hasRelatedWork W93121300 @default.
- W2949948293 isParatext "false" @default.
- W2949948293 isRetracted "false" @default.
- W2949948293 magId "2949948293" @default.
- W2949948293 workType "article" @default.